✦ LIBER ✦

The cardiovascular effects of etilefrine

✍ Scribed by A. J. Coleman; W. P. Leary; A. C. Asmal

Publisher: Springer
Year: 1975
Tongue: English
Weight: 449 KB
Volume: 8
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00616413

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ A. J. Coleman; W. P. Leary; A. C. Asmal 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 449 KB

Intravenous etilefrine increases the pulse rate, cardiac output, stroke volume, central venous pressure and mean arterial pressure of healthy individuals. Peripheral vascular resistance falls during the infusion of 1-8 mg etilefrine but begins to rise at higher dosage. Marked falls in pulse rate, ca

Cardiovascular effects of the thiazolidi

Cardiovascular effects of the thiazolidinediones

✍ Rehan Qayyum; Peter Schulman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Dihydroergotamine increases the bioavail

Dihydroergotamine increases the bioavailability of orally administered etilefrine

✍ J. H. Hengstmann; R. Hengstmann; S. Schwonzen; H. J. Dengler 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 588 KB

Adverse Cardiovascular Effects of the Co

Adverse Cardiovascular Effects of the Coxibs

✍ Jean-Michel Dogne; Claudiu T. Supuran; Domenico Pratico 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

Cardiovascular effects of bulbocapnine

✍ T. Fakouhi; T. D. Darby; R. S. McCutcheon 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB

concluded from the values of KAB and percent biophasic availability listed in Tables I1 andI11 that it is opposite to that expected on the basis of this consideration alone. The increased percent biophasic availability observed at pH 5.0 as equal to 73.8 %, relative to 43.3 at pH 7.4, may be specula

Cardiovascular effects of paroxetine

✍ H. Kuhs; G. A. E. Rudolf 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 403 KB